Medicaid coverage
Minnesota: what Medicaid covers
Minnesota keeps a weight management agents class with Saxenda and Wegovy preferred, and orlistat, Xenical and Zepbound non-preferred. The claims record agrees with the preference: Minnesota reimbursed 19,166 Wegovy prescriptions against 7,043 Zepbound in the first quarter of 2026.
| Drug | Position | Criteria |
|---|---|---|
| Semaglutide | Prior authorization | Wegovy is a preferred weight management agent |
| Tirzepatide | Prior authorization | Zepbound is non-preferred, so a preferred agent has to be tried first |
| Liraglutide | Prior authorization | Saxenda is a preferred weight management agent |
-
Semaglutide Prior authorization
Wegovy is a preferred weight management agent
-
Tirzepatide Prior authorization
Zepbound is non-preferred, so a preferred agent has to be tried first
-
Liraglutide Prior authorization
Saxenda is a preferred weight management agent
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
Minnesota Fee-for-Service and Managed Care Medicaid Uniform Preferred Drug List
Minnesota Department of Human Services Primary text read and checked Checked August 25, 2026